Cargando…
Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy
HIGHLIGHTS: Cardiac-specific Dsg2 deletion induces excessive cardiac fibrosis in mice. Fenofibrate alleviates cardiac fibrosis in CS-Dsg2(−/−) mice. Cardiac-specific activation of PPARα ameliorates cardiac fibrosis in CS-Dsg2(−/−) mice. The inhibitory effect of PPARα on cardiac fibrosis is mediated...
Autores principales: | Qiu, Zirui, Zhao, Yawen, Tao, Tian, Guo, Wenying, Liu, Ruonan, Huang, Jingmin, Xu, Geyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601208/ https://www.ncbi.nlm.nih.gov/pubmed/36291052 http://dx.doi.org/10.3390/cells11203184 |
Ejemplares similares
-
Reactivation of PPARα alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy
por: Lin, Yubi, et al.
Publicado: (2023) -
Arrhythmogenic cardiomyopathy related DSG2 mutations affect desmosomal cadherin binding kinetics
por: Dieding, Mareike, et al.
Publicado: (2017) -
Misdiagnosed myocarditis in arrhythmogenic cardiomyopathy induced by a homozygous variant of DSG2: a case report
por: Liu, Xuwei, et al.
Publicado: (2023) -
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy
por: Pilichou, Kalliopi, et al.
Publicado: (2009) -
PKP2 and DSG2 genetic variations in Latvian arrhythmogenic right ventricular dysplasia/cardiomyopathy registry patients
por: Bidina, Luize, et al.
Publicado: (2018)